Solius Labs, Inc. — SEC Form D Filing
Solius Labs, Inc. filed an SEC Form D on May 14, 2026, reporting $3.50M raised in Health Technology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- May 14, 2026
- Amount reported
- $3.50M
- Round stage
- Pre-Seed
- Industry
- Health Technology
- Website
- https://www.solius.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
People may experience insufficient exposure to beneficial sunlight, leading to potential health issues without a way to safely manage UV exposure.
Solution
Solius Labs, Inc. is developing a personalized sunlight device that analyzes your skin and delivers an optimal dose of UVB light therapy with minimal UV risk.
Why now
As awareness of the health benefits of sunlight increases, there is a growing need for safe and personalized UV exposure solutions.
Verdict
Investors rallied behind Solius Labs because the urgency around personalized health solutions offered a fresh narrative in a crowded wellness market, not because the device significantly differentiated itself from existing options. They implicitly bet on rising health trends and the increasing awareness of UV exposure's benefits to attract health-conscious consumers. However, the limited upside lies in an unproven technology and the possibility of rapid commoditization as similar products emerge.
Source: SEC EDGAR Form D filing